1262 Mrv0541 02231215212D 16 17 0 0 1 0 999 V2000 3.7464 -1.1305 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1816 -2.5826 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.7969 -2.4964 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 0.1794 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 0.1794 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 1.4169 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 1.4169 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 2.6545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.6665 -1.9152 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 2.4115 -1.1305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4915 -1.9152 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.0790 -0.6456 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 3.9764 -2.5826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 0.5919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 0.5919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0790 1.8294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 11 1 0 0 0 0 1 12 1 0 0 0 0 9 2 1 1 0 0 0 3 13 1 0 0 0 0 4 14 2 0 0 0 0 12 5 1 6 0 0 0 5 14 1 0 0 0 0 5 15 1 0 0 0 0 6 14 1 0 0 0 0 6 16 2 0 0 0 0 7 15 2 0 0 0 0 7 16 1 0 0 0 0 8 16 1 0 0 0 0 9 10 1 0 0 0 0 9 11 1 0 0 0 0 10 12 1 0 0 0 0 11 13 1 6 0 0 0 M END > DB01262 > drugbank > NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1 > InChI=1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1 > XAUDJQYHKZQPEU-KVQBGUIXSA-N > C8H12N4O4 > 228.2053 > 228.085854892 > 7 > 28 > 1.1165964517753615e-05 > 21.152792212911585 > 1 > 3 > 0 > 0 > 4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydro-1,3,5-triazin-2-one > -1.96 > -2.1646948889999997 > -1.62 > 0 > 0 > 2 > 0 > 14.787462757393836 > 13.89482653451755 > 2.0930619292819053 > 120.73999999999998 > 50.6825 > 2 > 1 > 5.50e+00 g/l > tetrahydrofolic acid > 0 > DB01262 > approved; investigational > Decitabine > 4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one; 5-aza-2'-deoxycytidine; 5-azadeoxycytidine; DAC; Decitabina; Decitabine > Dacogen; Decitabine; Demylocan; Inqovi $$$$